-
Je něco špatně v tomto záznamu ?
Comparative effects of microtubules disruption on glucocorticoid receptor functions in proliferating and quiescent cells
R. Vrzal, S. Gerbal-Chaloin, P. Maurel, Z. Dvorák,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
PubMed
20448266
DOI
10.1177/1091581810366486
Knihovny.cz E-zdroje
- MeSH
- aktivace enzymů MeSH
- buněčný cyklus účinky léků MeSH
- časové faktory MeSH
- dexamethason metabolismus MeSH
- extracelulárním signálem regulované MAP kinasy metabolismus MeSH
- fluorescenční mikroskopie MeSH
- HeLa buňky MeSH
- hepatocyty účinky léků metabolismus ultrastruktura MeSH
- kolchicin farmakologie MeSH
- lidé MeSH
- ligandy MeSH
- mikrotubuly účinky léků ultrastruktura MeSH
- modulátory tubulinu farmakologie MeSH
- proliferace buněk účinky léků MeSH
- průtoková cytometrie MeSH
- receptory glukokortikoidů metabolismus fyziologie MeSH
- signální transdukce účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
We have recently demonstrated that the alkaloid colchicine (COL) inhibits glucocorticoid receptor (GR) transcriptional activity. In addition, we described proteasome-mediated degradation of GR in COL-treated HeLa cells. While these effects were previously attributed to cell cycle arrest in G2/M phase, this explanation is not applicable for nonproliferating cells such as human hepatocytes (HH). In the current study, we compared COL-mediated microtubule disruption and cell cycle arrest with selected GR functions in HeLa cells and HH as models of proliferating and quiescent cells, respectively. Microtubule disruption led to irreversible decrease in GR binding capacity and protein level in HeLa cells. None of the parameters was restored 24 hours after COL withdrawal. In contrast, dexamethasone (DEX) binding was increased in HH at the beginning of the treatment, with following transient activation of extracellular signal-regulated kinase (ERK). The findings of these investigations emphasize the GR-signaling differences between primary and transformed cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025732
- 003
- CZ-PrNML
- 005
- 20121207110727.0
- 007
- ta
- 008
- 120817s2010 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1177/1091581810366486 $2 doi
- 035 __
- $a (PubMed)20448266
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vrzal, Radim $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University Olomouc, Slechtitelů 11, Olomouc, Czech Republic. radim.vrzal@email.cz
- 245 10
- $a Comparative effects of microtubules disruption on glucocorticoid receptor functions in proliferating and quiescent cells / $c R. Vrzal, S. Gerbal-Chaloin, P. Maurel, Z. Dvorák,
- 520 9_
- $a We have recently demonstrated that the alkaloid colchicine (COL) inhibits glucocorticoid receptor (GR) transcriptional activity. In addition, we described proteasome-mediated degradation of GR in COL-treated HeLa cells. While these effects were previously attributed to cell cycle arrest in G2/M phase, this explanation is not applicable for nonproliferating cells such as human hepatocytes (HH). In the current study, we compared COL-mediated microtubule disruption and cell cycle arrest with selected GR functions in HeLa cells and HH as models of proliferating and quiescent cells, respectively. Microtubule disruption led to irreversible decrease in GR binding capacity and protein level in HeLa cells. None of the parameters was restored 24 hours after COL withdrawal. In contrast, dexamethasone (DEX) binding was increased in HH at the beginning of the treatment, with following transient activation of extracellular signal-regulated kinase (ERK). The findings of these investigations emphasize the GR-signaling differences between primary and transformed cells.
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kolchicin $x farmakologie $7 D003078
- 650 _2
- $a dexamethason $x metabolismus $7 D003907
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a extracelulárním signálem regulované MAP kinasy $x metabolismus $7 D048049
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a hepatocyty $x účinky léků $x metabolismus $x ultrastruktura $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a fluorescenční mikroskopie $7 D008856
- 650 _2
- $a mikrotubuly $x účinky léků $x ultrastruktura $7 D008870
- 650 _2
- $a receptory glukokortikoidů $x metabolismus $x fyziologie $7 D011965
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a modulátory tubulinu $x farmakologie $7 D050257
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gerbal-Chaloin, Sabine
- 700 1_
- $a Maurel, Patrick
- 700 1_
- $a Dvorák, Zdenĕk
- 773 0_
- $w MED00006203 $t International journal of toxicology $x 1092-874X $g Roč. 29, č. 3 (2010), s. 326-35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20448266 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207110802 $b ABA008
- 999 __
- $a ok $b bmc $g 947774 $s 783078
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 29 $c 3 $d 326-35 $i 1092-874X $m International journal of toxicology $n Int J Toxicol $x MED00006203
- LZP __
- $a Pubmed-20120817/10/03